<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01309893</url>
  </required_header>
  <id_info>
    <org_study_id>687E</org_study_id>
    <nct_id>NCT01309893</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate a New Silicone Hydrogel Contact Lens</brief_title>
  <official_title>A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the clinical feasibility and to evaluate the
      product performance of investigational contact lenses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance High Contrast logMAR Visual Acuity at 1 Week</measure>
    <time_frame>Baseline &amp; 1 week</time_frame>
    <description>Mean difference in distance high contrast logMAR over all lens VAs (visual acuity) from Baseline and 1 Week</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Slit Lamp Findings ≥ Grade 2</measure>
    <time_frame>1 week</time_frame>
    <description>Slit lamp findings are measured on a scale of 0-4, where 0=none, and 4=severe. The slit lamp exam is a routine procedure done to evaluate eye health and determine eligibility for clinical trial. It provides view of the different parts of the eye. During the exam, a doctor can look at the front parts of the eye, including the cornea, the lens, the iris and other parts of the anterior segment of the eye. Fluorescein dye may be used during a slit lamp examination to make it easier to detect inflammation, infections, or injured area on the cornea.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Comfort</measure>
    <time_frame>1 week</time_frame>
    <description>Comfort measured by participant on a scale of 0-100 with 100 being the most favorable.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Investigational Lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bausch &amp; Lomb investigational silicone hydrogel contact lens for 1 week; then issued Air Optix Aqua Lens for 1 week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Air Optix Aqua Lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ciba Vision Air Optix Aqua contact lens for 1 week; then issued Investigational Lens for 1 week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Investigational Lens</intervention_name>
    <description>Lenses worn on a daily wear basis for one week</description>
    <arm_group_label>Investigational Lens</arm_group_label>
    <arm_group_label>Air Optix Aqua Lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Air Optix Aqua lens</intervention_name>
    <description>Lenses worn on a daily wear basis for one week</description>
    <arm_group_label>Investigational Lens</arm_group_label>
    <arm_group_label>Air Optix Aqua Lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have physiologically normal anterior segments not exhibiting clinically significant
             biomicroscopy findings.

          -  Be myopic and require lens correction from -0.50 D to -5.50 D in each eye.

        Exclusion Criteria:

          -  Any systemic disease affecting ocular health.

          -  Using any systemic or topical medications that will affect ocular physiology or lens
             performance.

          -  An active ocular disease, any corneal infiltrative response or are using any ocular
             medications.

          -  Any &quot;Present&quot; finding during the slit lamp examination that, in the Investigator's
             judgment, interferes with contact lens wear.

          -  Allergic to any component in the study care products.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Steffen, OD, MS</last_name>
    <role>Study Director</role>
    <affiliation>Bausch &amp; Lomb Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bausch &amp; Lomb</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2011</study_first_submitted>
  <study_first_submitted_qc>March 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2011</study_first_posted>
  <results_first_submitted>November 4, 2014</results_first_submitted>
  <results_first_submitted_qc>November 20, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 24, 2014</results_first_posted>
  <last_update_submitted>November 20, 2014</last_update_submitted>
  <last_update_submitted_qc>November 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contact lens</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants recruited for this 2-week study conducted at three investigational sites in the USA. The first participant was enrolled on 12/17/2010; the last participant exited the study on 01/20/2011.</recruitment_details>
      <pre_assignment_details>66 participants enrolled; 64 participants completed. Half wore Investigational Lens for 1 week then crossed over to Air Optix Aqua lens for 1 week. The other half wore Air Optix Aqua Lens for 1 week then crossed over to Investigational Lens for 1 week. The order of lens use was randomized and participant-masked.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Investigational Lens First, Then Air Optix Aqua Lens</title>
          <description>Enrolled participants spent 1 week using Investigational Lens, and then crossed over to 1 week using Air Optix Aqua lens. The order of contact lens use was randomized and participant-masked.</description>
        </group>
        <group group_id="P2">
          <title>Air Optix Aqua Lens First, Then Investigational Lens</title>
          <description>Enrolled participants spent 1 week using Air Optix Aqua Lens, and then crossed over to 1 week using Investigational Lens. The order of contact lens use was randomized and participant-masked.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Week 1 - First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Week 2 - Crossover Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missed crossover visit</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All eligible enrolled participants</population>
      <group_list>
        <group group_id="B1">
          <title>Entire Study Population</title>
          <description>All eligible enrolled participants</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="66"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.6" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Distance High Contrast logMAR Visual Acuity at 1 Week</title>
        <description>Mean difference in distance high contrast logMAR over all lens VAs (visual acuity) from Baseline and 1 Week</description>
        <time_frame>Baseline &amp; 1 week</time_frame>
        <population>All eligible, dispensed eyes</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Lens</title>
            <description>Bausch &amp; Lomb investigational silicone hydrogel contact lens
Investigational Lens: Lenses worn on a daily wear basis for one week</description>
          </group>
          <group group_id="O2">
            <title>Air Optix Aqua Lens</title>
            <description>Ciba Vision Air Optix Aqua contact lens
Air Optix Aqua lens: Lenses worn on a daily wear basis for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Distance High Contrast logMAR Visual Acuity at 1 Week</title>
          <description>Mean difference in distance high contrast logMAR over all lens VAs (visual acuity) from Baseline and 1 Week</description>
          <population>All eligible, dispensed eyes</population>
          <units>logMAR</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="66"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="132"/>
                <count group_id="O2" value="132"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.031" spread="0.069"/>
                    <measurement group_id="O2" value="-0.015" spread="0.071"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Slit Lamp Findings ≥ Grade 2</title>
        <description>Slit lamp findings are measured on a scale of 0-4, where 0=none, and 4=severe. The slit lamp exam is a routine procedure done to evaluate eye health and determine eligibility for clinical trial. It provides view of the different parts of the eye. During the exam, a doctor can look at the front parts of the eye, including the cornea, the lens, the iris and other parts of the anterior segment of the eye. Fluorescein dye may be used during a slit lamp examination to make it easier to detect inflammation, infections, or injured area on the cornea.</description>
        <time_frame>1 week</time_frame>
        <population>All dispensed eyes</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Lens</title>
            <description>Bausch &amp; Lomb investigational silicone hydrogel contact lens
Investigational Lens: Lenses worn on a daily wear basis for one week</description>
          </group>
          <group group_id="O2">
            <title>Air Optix Aqua Lens</title>
            <description>Ciba Vision Air Optix Aqua contact lens
Air Optix Aqua lens: Lenses worn on a daily wear basis for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Slit Lamp Findings ≥ Grade 2</title>
          <description>Slit lamp findings are measured on a scale of 0-4, where 0=none, and 4=severe. The slit lamp exam is a routine procedure done to evaluate eye health and determine eligibility for clinical trial. It provides view of the different parts of the eye. During the exam, a doctor can look at the front parts of the eye, including the cornea, the lens, the iris and other parts of the anterior segment of the eye. Fluorescein dye may be used during a slit lamp examination to make it easier to detect inflammation, infections, or injured area on the cornea.</description>
          <population>All dispensed eyes</population>
          <units>eyes</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="65"/>
                <count group_id="O2" value="63"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="130"/>
                <count group_id="O2" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Comfort</title>
        <description>Comfort measured by participant on a scale of 0-100 with 100 being the most favorable.</description>
        <time_frame>1 week</time_frame>
        <population>All eligible dispensed eyes</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Lens</title>
            <description>Bausch &amp; Lomb investigational silicone hydrogel contact lens
Investigational Lens: Lenses worn on a daily wear basis for one week</description>
          </group>
          <group group_id="O2">
            <title>Air Optix Aqua Lens</title>
            <description>Ciba Vision Air Optix Aqua contact lens
Air Optix Aqua lens: Lenses worn on a daily wear basis for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Comfort</title>
          <description>Comfort measured by participant on a scale of 0-100 with 100 being the most favorable.</description>
          <population>All eligible dispensed eyes</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="63"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.3" spread="27.8"/>
                    <measurement group_id="O2" value="80.8" spread="27.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 week</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Investigational Lens</title>
          <description>Bausch &amp; Lomb investigational silicone hydrogel contact lens
Investigational Lens: Lenses worn on a daily wear basis for one week</description>
        </group>
        <group group_id="E2">
          <title>Air Optix Aqua Lens</title>
          <description>Ciba Vision Air Optix Aqua contact lens
Air Optix Aqua lens: Lenses worn on a daily wear basis for one week</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Robert Steffen</name_or_title>
      <organization>Bausch &amp; Lomb</organization>
      <phone>585 338-6399</phone>
      <email>robert.steffen@bausch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

